Savi, Pierre <br/><br/>
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.  [electronic resource] 

 -  Seminars in thrombosis and hemostasis  Apr 2005 
 - 174-83 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>0094-6176 
<br/><br/><label>Standard No.: </label>10.1055/s-2005-869523  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--pharmacology<br/>Animals<br/>Arteriosclerosis--complications<br/>Aspirin--pharmacology<br/>Clinical Trials as Topic<br/>Clopidogrel<br/>Cohort Studies<br/>Double-Blind Method<br/>Drug Resistance<br/>Fibrinolytic Agents--pharmacokinetics<br/>Forecasting<br/>Humans<br/>Membrane Proteins--antagonists & inhibitors<br/>Meta-Analysis as Topic<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacokinetics<br/>Purinergic P2 Receptor Antagonists<br/>Pyridines--pharmacology<br/>Randomized Controlled Trials as Topic<br/>Rats<br/>Receptors, Purinergic P2<br/>Receptors, Purinergic P2Y12<br/>Thrombophilia--drug therapy<br/>Thrombosis--etiology<br/>Ticlopidine--analogs & derivatives